Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
Streetwise Reports
The Gold Report
The Energy Report
The Life Sciences Report
Research Reports
The Life Sciences Report
Articles
Biotechnology / Pharmaceuticals
Cannabis
Healthcare Services
Life Sciences Tools & Diagnostics
Medical Devices
Regenerative Medicine
Disclosures
Featured news in
The Life Sciences Report
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
BrainStorm Cell Therapeutics Announces Outcome of FDA Meeting on NurOwn® in ALS (12/7/2023)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
BRAINSTORM INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Brainstorm To Contact Him Directly To Discuss Their Options (12/7/2023)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - BCLI (12/7/2023)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
SHAREHOLDER ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of January 2, 2024 in Brainstorm Cell Lawsuit - BCLI (12/7/2023)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
SHAREHOLDER ALERT: Contact Levi & Korsinsky Before January 2, 2024 to Discuss Your Rights - BCLI (12/7/2023)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
BRAINSTORM SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In Brainstorm To Contact Him Directly To Discuss Their Options (12/5/2023)
view
BrainStorm Cell Therapeutics Inc.
(BCLI:NASDAQ)
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Brainstorm Cell Therapeutics Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - BCLI (12/5/2023)
view